Dr Sherry Wu
Dr

Sherry Wu

Email: 
Phone: 
+61 7 336 52785

Availability

Dr Sherry Wu is:
Available for supervision

Qualifications

  • Bachelor (Honours), The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Search Professor Sherry Wu’s works on UQ eSpace

62 works between 2009 and 2024
All (62) Journal Article (57) Book Chapter (2) Conference Publication (3)

1 - 20 of 62 works

2024

Journal Article

Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering

Alharbi, Mona, Lai, Andrew, Godbole, Nihar, Guanzon, Dominic, Nair, Soumyalekshmi, Zuñiga, Felipe, Quinn, Alexander, Yang, Mengliu, Wu, Sherry Y. and Salomon, Carlos (2024). Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. International Journal of Cancer, 155 (8), 1510-1523. doi: 10.1002/ijc.35055

Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering

2024

Journal Article

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

Wilkinson, Andrew N., Chen, Rui, Coleborn, Elaina, Neilson, Trent, Le, Khang, Bhavsar, Chintan, Wang, Yue, Atluri, Sharat, Irgam, Gowri, Wong, Kiefer, Yang, Da, Steptoe, Raymond and Wu, Sherry Y. (2024). Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunology, Immunotherapy, 73 (5) 80, 80. doi: 10.1007/s00262-024-03674-w

Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth

2023

Journal Article

miR-146a inhibits ovarian tumour growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration

Chen, Rui, Coleborn, Elaina, Bhavsar, Chintan, Wang, Yue, Alim, Louisa, Wilkinson, Andrew N., Tran, Michelle A., Irgam, Gowri, Atluri, Sharat, Wong, Kiefer, Shim, Jae-Jun, Adityan, Siddharth, Lee, Ju-Seog, Overwijk, Willem W., Steptoe, Raymond, Yang, Da and Wu, Sherry Y. (2023). miR-146a inhibits ovarian tumour growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration. Molecular Therapy - Oncolytics, 31 100725, 1-15. doi: 10.1016/j.omto.2023.09.001

miR-146a inhibits ovarian tumour growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration

2022

Journal Article

Molecular analysis of short- versus long-term survivors of high-grade serous ovarian carcinoma

Stur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y., Mangala, Lingegowda S., Yao, Hui, Wang, Ying, Ram, Prahlad T., Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S., Levine, Douglas A., Lutgendorf, Susan K., Liu, Jinsong, Moore, Kathleen N., Baggerly, Keith A., Karlan, Beth Y. and Sood, Anil K. (2022). Molecular analysis of short- versus long-term survivors of high-grade serous ovarian carcinoma. Cancers, 14 (17) 4198, 4198. doi: 10.3390/cancers14174198

Molecular analysis of short- versus long-term survivors of high-grade serous ovarian carcinoma

2022

Conference Publication

Using action learning to develop a model for inclusive teaching in a COVID-split cohort

Aland, Claire, Oancea, Iulia, Midwinter, Mark, Pillai, Suja, Manchadi, Mary-Louise, Reichelt, Melissa and Wu, Sherry (2022). Using action learning to develop a model for inclusive teaching in a COVID-split cohort. 26th Annual International Association for Medical Science Educators, Denver, CO, United States, 4-7 June 2022.

Using action learning to develop a model for inclusive teaching in a COVID-split cohort

2021

Journal Article

Gene body methylation of the lymphocyte-specific gene CARD11 results in its overexpression and regulates cancer mTOR signaling

McGuire, Michael H., Dasari, Santosh K., Yao, Hui, Wen, Yunfei, Mangala, Lingegowda S., Bayraktar, Emine, Ma, Wencai, Ivan, Cristina, Shoshan, Einav, Wu, Sherry Y., Jonasch, Eric, Bar-Eli, Menashe, Wang, Jing, Baggerly, Keith A. and Sood, Anil K. (2021). Gene body methylation of the lymphocyte-specific gene CARD11 results in its overexpression and regulates cancer mTOR signaling. Molecular Cancer Research, 19 (11), 1917-1928. doi: 10.1158/1541-7786.MCR-20-0753

Gene body methylation of the lymphocyte-specific gene CARD11 results in its overexpression and regulates cancer mTOR signaling

2021

Journal Article

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

Ma, Shaolin, Mangala, Lingegowda S., Hu, Wen, Bayaktar, Emine, Yokoi, Akira, Hu, Wei, Pradeep, Sunila, Lee, Sanghoon, Piehowski, Paul D., Villar-Prados, Alejandro, Wu, Sherry Y., McGuire, Michael H., Lara, Olivia D., Rodriguez-Aguayo, Cristian, LaFargue, Christopher J., Jennings, Nicholas B., Rodland, Karin D., Liu, Tao, Kundra, Vikas, Ram, Prahlad T., Ramakrishnan, Sundaram, Lopez-Berestein, Gabriel, Coleman, Robert L. and Sood, Anil K. (2021). CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Reports, 36 (7). doi: 10.1016/j.celrep.2021.109549

CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance

2021

Journal Article

Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype

Ma, Shaolin, McGuire, Michael H., Mangala, Lingegowda S., Lee, Sanghoon, Stur, Elaine, Hu, Wen, Bayraktar, Emine, Villar-Prados, Alejandro, Ivan, Cristina, Wu, Sherry Y., Yokoi, Akira, Dasari, Santosh K., Jennings, Nicholas B., Liu, Jinsong, Lopez-Berestein, Gabriel, Ram, Prahlad and Sood, Anil K. (2021). Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype. Cell Reports, 34 (6). doi: 10.1016/j.celrep.2021.108726

Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype

2020

Journal Article

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil

Mori, Noriko, Mironchik, Yelena, Wildes, Flonné, Wu, Sherry Y., Mori, Kanami, Krishnamachary, Balaji and Bhujwalla, Zaver M. (2020). HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil. Current Cancer Reports, 2 (1), 54-63. doi: 10.25082/CCR.2020.01.005

HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil

2020

Journal Article

Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation

Adityan, Siddharth, Tran, Michelle, Bhavsar, Chintan and Wu, Sherry Y. (2020). Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation. Journal of Controlled Release, 327 (Acta Biomater. 62 2017), 512-532. doi: 10.1016/j.jconrel.2020.08.016

Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation

2020

Journal Article

The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis

Noh, Kyunghee, Duc-Hiep Bach, , Choi, Hyun-Jin, Kim, Mark S., Wu, Sherry Y., Pradeep, Sunila, Ivan, Cristina, Cho, Min-Soon, Bayraktar, Emine, Rodriguez-Aguayo, Cristian, Dasari, Santosh K., Stur, Elaine, Mangala, Lingegowda S., Lopez-Berestein, Gabriel and Sood, Anil K. (2020). The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene, 40 (2), 384-395. doi: 10.1038/s41388-020-01517-3

The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis

2020

Journal Article

Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles

Liu, Yuan, Wu, Sherry, Koo, Yeonjong, Yang, An, Dai, Yanwan, Khant, Htet, Osman, Samantha R., Chowdhury, Mamur, Wei, Haichao, Li, Yang, Court, Karem, Hwang, Elaine, Wen, Yunfei, Dasari, Santosh K., Nguyen, Michael, Tang, E. Chia-Cheng, Chehab, E. Wassim, de Val, Natalia, Braam, Janet and Sood, Anil K. (2020). Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles. Nanomedicine-Nanotechnology Biology and Medicine, 29 102271. doi: 10.1016/j.nano.2020.102271

Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles

2020

Journal Article

NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors

Miyake, Takahito M., Pradeep, Sunila, Bayraktar, Emine, Stur, Elaine, Handley, Katelyn F., Wu, Sherry Y., Rodriguez-Aguayo, Cristian, Lee, Ju-Seog, Lopez-Berestein, Gabriel, Coleman, Robert L. and Sood, Anil K. (2020). NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors. Molecular Cancer Therapeutics, 19 (8), 1727-1735. doi: 10.1158/1535-7163.MCT-19-0977

NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors

2020

Conference Publication

Molecular analysis of short- vs. long-term ovarian cancer survivors

Stur, Elaine, Dal Molin, Graziela Zibetti, Wu, Sherry, Baggerly, Keith, Tworoger, Shelley, Levine, Douglas, Karlan, Beth, Moore, Kathleen, Lutgendorf, Susan and Sood, Anil (2020). Molecular analysis of short- vs. long-term ovarian cancer survivors. AACR Special Conference on Advances in Ovarian Cancer Research, Atlanta, GA United States, 13-16 September 2019. Philadelphia, PA United States: American Association for Cancer Research.

Molecular analysis of short- vs. long-term ovarian cancer survivors

2019

Journal Article

Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention

Shi, Sixiang, Li, Tingting, Wen, Xiaofei, Wu, Sherry Y., Xiong, Chiyi, Zhao, Jun, Lincha, Victor R., Chow, Diana S., Liu, Yiyao, Sood, Anil K. and Li, Chun (2019). Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention. Bioconjugate Chemistry, 30 (10), 2675-2683. doi: 10.1021/acs.bioconjchem.9b00587

Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention

2019

Journal Article

Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma

Endo-Munoz, Liliana, Bennett, Tristram C., Topkas, Eleni, Wu, Sherry Y., Thamm, Douglas H., Brockley, Laura, Cooper, Maureen, Sommerville, Scott, Thomson, Maurine, O'Connell, Kathleen, Lane, Amy, Bird, Guy, Peaston, Anne, Matigian, Nicholas, Straw, Rodney C. and Saunders, Nicholas A. (2019). Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma. Veterinary and Comparative Oncology, 18 (2) vco.12533, 206-213. doi: 10.1111/vco.12533

Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma

2019

Journal Article

Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells

McGuire, Michael H., Herbrich, Shelley M., Dasari, Santosh K., Wu, Sherry Y., Wang, Ying, Rupaimoole, Rajesha, Lopez-Berestein, Gabriel, Baggerly, Keith A. and Sood, Anil K. (2019). Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells. Ebiomedicine, 43, 127-137. doi: 10.1016/j.ebiom.2019.04.045

Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells

2019

Journal Article

Predicting novel therapies and targets: regulation of notch3 by the Bromodomain protein BRD4

Villar-Prados, Alejandro, Wu, Sherry Y., Court, Karem A., Ma, Shaolin, LaFargue, Christopher, Chowdhury, Mamur A., Engelhardt, Margaret I., Ivan, Cristina, Ram, Prahlad T., Wang, Ying, Baggerly, Keith, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Ming-Yang, Shyh, Maloney, David J., Yoshioka, Makoto, Strovel, Jeffrey W., Roszik, Jason and Sood, Anil K. (2019). Predicting novel therapies and targets: regulation of notch3 by the Bromodomain protein BRD4. Molecular Cancer Therapeutics, 18 (2), 421-436. doi: 10.1158/1535-7163.MCT-18-0365

Predicting novel therapies and targets: regulation of notch3 by the Bromodomain protein BRD4

2018

Journal Article

Advances and challenges in nanomedicine

Hua, Susan and Wu, Sherry Y. (2018). Advances and challenges in nanomedicine. Frontiers in Pharmacology, 9 (Nov) 1397, 1397. doi: 10.3389/fphar.2018.01397

Advances and challenges in nanomedicine

2018

Journal Article

The advances and challenges in utilizing exosomes for delivering cancer therapeutics

Yang, Mengliu and Wu, Sherry Y. (2018). The advances and challenges in utilizing exosomes for delivering cancer therapeutics. Frontiers in Pharmacology, 9 (JUL) 735, 735. doi: 10.3389/fphar.2018.00735

The advances and challenges in utilizing exosomes for delivering cancer therapeutics

Current funding

  • 2023 - 2026
    In vivo genetic engineering of T-cells for cancer treatment using novel exosome mimetic nanoparticles
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2019
    Advanced Nanoparticle, Colloid and Microparticle Characterisation and Precision Engineering Nanosystems Facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2019 - 2022
    Harnessing the immune system to battle ovarian cancer: A novel approach using naturally occurring exosomes
    NHMRC Project Grant
    Open grant
  • 2019
    Harnessing the immune system to battle ovarian cancer: A novel approach using naturally occurring exosomes
    UQ Foundation Research Excellence Awards
    Open grant
  • 2019
    Vevo 3100 Imaging System for ultrahigh resolution and frame rate echocardiographic assessment of small animals.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Re-activating anti-tumour immunity by targeting N-MYC-Lec7 axis in ovarian cancer
    Ovarian Cancer Research Foundation
    Open grant
  • 2018
    Re-activating anti-tumour immunity by targeting N-MYC-Lec7 axis in ovarian cancer
    Ovarian Cancer Research Foundation
    Open grant
  • 2018 - 2020
    Re-activating anti-tumor immunity using non-coding RNAs
    Ovarian Cancer Research Foundation Alliance
    Open grant

Availability

Dr Sherry Wu is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Developing new strategies to overcome immune suppression in cancer

    Principal Advisor

    Other advisors: Honorary Professor John Hooper

  • Master Philosophy

    Investigating the role of exosomes in cancer progression and immunology

    Principal Advisor

    Other advisors: Professor Gregory Monteith

  • Doctor Philosophy

    Developing novel strategies to overcome immune suppression in cancer

    Principal Advisor

    Other advisors: Honorary Professor John Hooper

Completed supervision

Enquiries

For media enquiries about Dr Sherry Wu's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au